Assuming tumor volume change will be shown to be a biomarker for therapeutic response, accurate early quantification of tumor volume change could lead to interactively adapting an individual patient’s therapy such as drug or dose modification to achieve optimal response as well as shorter phase III clinical trials. Standard techniques for response evaluation like RECIST 1.1 or WHO measurement methods have limited effectiveness in accurately assessing small, early changes. Most current approaches estimate a tumor's change indirectly by independently segmenting it in interval exams and then subtracting the segmented volumes to obtain a change estimate. Ensuring the consistency of these independent segmentations across interval exams can be a ...
INTRODUCTION:In oncological drug development, animal studies continue to play a central role in whic...
AbstractRATIONALE: Early detection of tumor response to therapy is a key goal. Finding measurement a...
The objective, accurate, and standardized evaluation of tumor response to treatment is an indispensa...
Assuming tumor volume change will be shown to be a biomarker for therapeutic response, accurate earl...
RATIONALE: Early detection of tumor response to therapy is a key goal. Finding measurement algorithm...
RATIONALE: Early detection of tumor response to therapy is a key goal. Finding measurement algorithm...
OBJECTIVE: This study was designed to characterize the reproducibility of measurement for tumor volu...
AbstractRATIONALE AND OBJECTIVES: This article describes issues and methods that are specific to the...
RATIONALE AND OBJECTIVES: This article describes issues and methods that are specific to the measure...
RATIONALE AND OBJECTIVES: This article describes issues and methods that are specific to the measure...
AbstractImaging biomarkers capable of early quantification of tumor response to therapy would provid...
Rationale and objectivesTumor volume change has potential as a biomarker for diagnosis, therapy plan...
Imaging biomarkers capable of early quantification of tumor response to therapy would provide an opp...
Abstract—The pulmonary nodule is the most common manifes-tation of lung cancer, the most deadly of a...
Brain tumor analysis is moving towards volumetric assessment of magnetic resonance imaging (MRI), pr...
INTRODUCTION:In oncological drug development, animal studies continue to play a central role in whic...
AbstractRATIONALE: Early detection of tumor response to therapy is a key goal. Finding measurement a...
The objective, accurate, and standardized evaluation of tumor response to treatment is an indispensa...
Assuming tumor volume change will be shown to be a biomarker for therapeutic response, accurate earl...
RATIONALE: Early detection of tumor response to therapy is a key goal. Finding measurement algorithm...
RATIONALE: Early detection of tumor response to therapy is a key goal. Finding measurement algorithm...
OBJECTIVE: This study was designed to characterize the reproducibility of measurement for tumor volu...
AbstractRATIONALE AND OBJECTIVES: This article describes issues and methods that are specific to the...
RATIONALE AND OBJECTIVES: This article describes issues and methods that are specific to the measure...
RATIONALE AND OBJECTIVES: This article describes issues and methods that are specific to the measure...
AbstractImaging biomarkers capable of early quantification of tumor response to therapy would provid...
Rationale and objectivesTumor volume change has potential as a biomarker for diagnosis, therapy plan...
Imaging biomarkers capable of early quantification of tumor response to therapy would provide an opp...
Abstract—The pulmonary nodule is the most common manifes-tation of lung cancer, the most deadly of a...
Brain tumor analysis is moving towards volumetric assessment of magnetic resonance imaging (MRI), pr...
INTRODUCTION:In oncological drug development, animal studies continue to play a central role in whic...
AbstractRATIONALE: Early detection of tumor response to therapy is a key goal. Finding measurement a...
The objective, accurate, and standardized evaluation of tumor response to treatment is an indispensa...